Inflammatory Myopathies Flashcards

1
Q

What antibody should be considered in a case of LGMD with negative genetic testing?

A

HMGCR ab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What inflammatory myopathies are associated with rapid myositis progression over days to weeks?

A

Viral myositis and immune-mediated necrotizing myopathy (especially anti-SRP antibodies).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the heliotrope sign in dermatomyositis?

A

Periorbital and upper eyelid violaceous discoloration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the Gottron sign?

A

Erythematous, scaly plaques over the MCP and IP joints.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the “V sign” rash?

A

Sun-exposed rash in the anterior chest seen in DM patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the shawl sign?

A

Erythematous rash on the posterior neck and shoulders seen in DM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the rash on the lateral thigh called in DM?

A

Holster sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the relevance of subcutaneous calcifications in dermatomyositis?

A

“Calcinosis cutis” is associated with anti-NXP-2 antibodies in dermatomyositis (often juvenile).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nail bed telangiectasias are associated with which antibodies in DM?

A

Anti – Mi-2 antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What condition is characterized by a hyperkeratotic eruption over the thumb and radial aspect of fingers?

A

Mechanic’s hands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a prominent feature of dermatomyositis with anti-MDA-5 antibodies?

A

Interstitial lung disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which myositis conditions are associated with interstitial lung disease?

A

-Dermatomyositis with anti-MDA-5 antibodies
-Antisynthetase syndrome (Jo 1, PL 7/12)
-Overlap myositis with systemic sclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What inflammatory myopathies are more likely to cause myocarditis?

A

IMNM and ICI-related myositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What inflammatory myositis is associated with pericarditis?

A

Anti-U1 RNP overlap myositis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gastrointestinal vasculopathy in juvenile dermatomyositis can lead to what complications?

A

Intestinal infarcts or hemorrhage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What inflammatory myopathy is associated with glomerulonephritis?

A

Anti-U1 RNP antibody overlap myositis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When can CK be normal in dermatomyositis and anti-synthetase syndrome?

A

When inflammation is limited to perimysium and fascia with minimal muscle pathology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What enzyme elevation is diagnostically helpful when CK is normal?

A

Selective aldolase elevation can be diagnostically helpful.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What myositis shows extreme CK elevations (>20 times normal) if untreated?

A

Immune-mediated necrotizing myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the yield of antibody testing in idiopathic inflammatory myopathies?

A

About 65% to 70%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the five antibodies related to dermatomyositis?

A

Anti-NXP-2
Anti-TIF1-γ
Anti-Mi-2
Anti-MDA-5
Anti-SAE.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Which antibodies have the strongest association with malignancy in dermatomyositis?

A

TIF1-γ antibodies
(Typically mild muscle but significant skin involvement)
Consider cancer screening up to 3 years after dx of myositis (per Kuschlaf 2024 AANEM lecture).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What phenotype is assoicated with NXP-2 abs?

A

Calcinosis cutis
Peripheral edema
Distal weakness
Higher malignancy risk in adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the characteristics of Anti-Mi-2 antibody in dermatomyositis?

A

Severe muscle weakness, acute onset, heliotrope rash, Gottron papules, nail fold pathology, good prognosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What complications are associated with anti-MDA-5 antibody syndrome?

A

Thrombotic complications, skin ulceration, palmar papules, and severe interstitial lung disease.

May have amyopathic dermatomyositis (like Tif1 gamma).

26
Q

What are characteristic symptoms of SAE abs in dermatomyositis?

A

Erythematous rashes and severe dysphagia.
Possibly inc cancer risk.
Least common DM abs.

27
Q

What non-neurologic risk has been associated with dermatomyositis?

A

An elevated cancer risk.

28
Q

What is the most common antibody found in antisynthetase syndrome?

A

Anti-Jo-1 antibody.

29
Q

What other antibodies are associated with antisynthetase syndrome besides anti-Jo-1.

A

PL-7, PL-12, OJ, EJ, KS, Zo, Ha.

30
Q

What is the dominant feature of anti-PL-7 and anti-PL-12 antibody antisynthetase syndrome?

A

Interstitial lung disease is the dominant feature.

31
Q

What percentage of immune-mediated necrotizing myopathy cases have specific antibodies detected?

A

About 65% of cases.

32
Q

What percentage of DM cases are seronegative?

A

About 30% (per Kuschlaf AANEM lecture 2024)

33
Q

Which antibodies are commonly detected in immune-mediated necrotizing myopathy?

A

Anti-SRP, anti-HMG-CoA reductase IgG, and rarely antimitochondrial M2 antibodies.

34
Q

What characterizes Anti-SRP antibody syndrome?

A

Severe weakness, rapid progression, and extremely high CK levels (typically five-digit).

Can have myocarditis and respiratory failure due to diaphragmatic weakness (or ILD).

35
Q

What can develop within months if SRP IMNM is not treated early?

A

Muscle fibrosis and fat replacement.

36
Q

What percentage of patients with anti-HMG-CoA reductase IgG myopathy are statin-naive?

A

At least one-third of patients are statin-naive.

37
Q

What subtypes of IMNM are associated with increased cancer risk?

A

HMGCR and seronegative

38
Q

What is the pathological manifestation of antimitochondrial antibody-related myositis in over 50% of cases?

A

Immune-mediated necrotizing myopathy (less commonly presents as a granulomatous myositis). 1/4 patients have primary biliary cirrhosis.

39
Q

Name myositis associated antibodies (associated with myositis but not specific for it)

A

U1 RNP
U2 RNP
SSA (most common)
PM Scl
Ku

40
Q

What percentage of systemic sclerosis/overlap myositis syndrome cases have anti-PM-Scl and anti-Ku antibodies?

41
Q

What Myositis associated antibodies are associated with dropped head syndrome?

A

PM-Scl-75 and PM-Scl-100.

42
Q

What systemic conditions are associated with anti-U1 RNP antibodies?

A

Glomerulonephritis and pericarditis.

43
Q

What does MRI show in dermatomyositis?

A

Edema in subcutaneous tissue, epimysium, perimysium, and patchy muscle edema.

44
Q

What characterizes immune-mediated necrotizing myopathy on MRI?

A

Severe diffuse edema and enhancement intramuscularly, with little to no fascial involvement.

45
Q

What can be seen early on MRI in anti-SRP antibody myopathy?

A

Fatty replacement and muscle atrophy may occur early in anti-SRP antibody myopathy.

46
Q

Who should be screened for malignancy in relation to dermatomyositis?

A

All adults over 40 with dermatomyositis, especially with anti-TIF1-γ and anti-NXP-2 antibodies.

47
Q

Incidence of cancer in antisynthetase syndrome, anti-SRP myopathy, or overlap myositis?

A

Low incidence; routine cancer screening not recommended.

48
Q

What is offered as a first-line treatment in anti-HMG-CoA reductase IgG myopathy?

49
Q

What symptoms are associated with immune checkpoint inhibitor-related myositis?

A

Proximal limb-girdle weakness, ocular myositis (diplopia, ptosis, resembling myasthenia gravis but neg AchR abs and neg RNS).

50
Q

How soon after starting immune checkpoint inhibitors do symptoms of myositis typically appear?

A

Symptoms typically appear within 1 to 2 months after initiation.

51
Q

Which muscles showed a predilection in immune checkpoint inhibitor-related myositis?

A

Axial muscles, especially neck extensor muscles.

52
Q

What did muscle biopsies usually show in ICI related myositis?

A

Immune-mediated necrotizing myopathy with clusters of necrotic fibers; inflammation was less common.

53
Q

What was observed about CK levels in ICI related myositis?

A

CK levels were elevated, yet lower than in other immune-mediated necrotizing myopathy subtypes.

54
Q

What can be used to treat immune-mediated necrotizing myopathy?

A

Steroids (IVIG if refractory). If mild symptoms do not need to d/c ICI (not sure I would have to guts to do this).

55
Q

What percentage of patients with COVID report myalgia?

A

50% of patients report myalgia.

56
Q

What percentage of patients show asymptomatic CK elevations in COVID?

A

16% to 33% show asymptomatic CK elevations.

57
Q

What are the three clinical phenotypes of myopathy associated with COVID-19?

A

Rhabdomyolysis

Classic dermatomyositis

Isolated paraspinal myositis.

59
Q

What is mixed connective tissue disease (MCTD)?

A

Type of overlap syndrome.

Main features of at least two overlapping connective tissue diseases including:
SLE, systemic sclerosis, rheumatoid arthritis, myositis.

Defined by the presence of anti-U1 RNP antibodies and Raynaud’s phenomenon

60
Q

What antibody is associated with immune mediated Rippling Muscle Disease?

A

Anti Cavin 4 abs
All should have percussion induced muscle rippling.

61
Q

What ab is seen with IBM?

A

NT5C1A
Seen in about 40-60% of IBM (no difference in seropostive or seronegative clinically)
Can see false + in other inflammatory myopathies, SLE/Sjogren’s, MND, VCP, and even in normal volunteers (per Kuschlaf AANEM 2024 lecture)